Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schiffer

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Nature Computational Science|January 4, 2024
Correlates of protection via modelingJoshua T Schiffer
The Journal of Infectious Diseases|January 27, 2023
The Continuing Puzzle of Defining Duration of Severe Acute Respiratory Syndrome Coronavirus 2 InfectivityJoshua T Schiffer
Frontiers in Immunology|August 3, 2013
Mucosal HSV-2 Specific CD8+ T-Cells Represent Containment of Prior Viral Shedding Rather than a Correlate of Future ProtectionJoshua T Schiffer
The Journal of Antimicrobial Chemotherapy|January 19, 2026
Strategies for mitigating severe COVID-19 in patients with haematological malignancy during the omicron eraKeiji Okinaka, Joshua T Schiffer
Frontiers in Immunology|November 22, 2024
Ensemble modeling of SARS-CoV-2 immune dynamics in immunologically naïve rhesus macaques predicts that potent, early innate immune responses drive viral eliminationCatherine Byrne, Joshua T Schiffer
The American Journal of Medicine|December 31, 2008
With jaundiced eyesChristine Durand, Joshua T Schiffer
Nature Medicine|March 8, 2013
Rapid host immune response and viral dynamics in herpes simplex virus-2 infectionJoshua T Schiffer, Lawrence Corey
Current Infectious Disease Reports|October 28, 2009
New concepts in understanding genital herpesJoshua T Schiffer, Lawrence Corey
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2012
Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapyJeffrey Thomas Schouten, Joshua T Schiffer
Discrete Applied Mathematics (Amsterdam, Netherlands : 1988)|March 6, 2012
T Schiffer, F Aurenhammer, M Demuth
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Nature Computational Science|January 4, 2024
Correlates of protection via modelingJoshua T Schiffer
The Journal of Infectious Diseases|January 27, 2023
The Continuing Puzzle of Defining Duration of Severe Acute Respiratory Syndrome Coronavirus 2 InfectivityJoshua T Schiffer
Frontiers in Immunology|August 3, 2013
Mucosal HSV-2 Specific CD8+ T-Cells Represent Containment of Prior Viral Shedding Rather than a Correlate of Future ProtectionJoshua T Schiffer
The Journal of Antimicrobial Chemotherapy|January 19, 2026
Strategies for mitigating severe COVID-19 in patients with haematological malignancy during the omicron eraKeiji Okinaka, Joshua T Schiffer
Frontiers in Immunology|November 22, 2024
Ensemble modeling of SARS-CoV-2 immune dynamics in immunologically naïve rhesus macaques predicts that potent, early innate immune responses drive viral eliminationCatherine Byrne, Joshua T Schiffer
The American Journal of Medicine|December 31, 2008
With jaundiced eyesChristine Durand, Joshua T Schiffer
Nature Medicine|March 8, 2013
Rapid host immune response and viral dynamics in herpes simplex virus-2 infectionJoshua T Schiffer, Lawrence Corey
Current Infectious Disease Reports|October 28, 2009
New concepts in understanding genital herpesJoshua T Schiffer, Lawrence Corey
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2012
Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapyJeffrey Thomas Schouten, Joshua T Schiffer
Discrete Applied Mathematics (Amsterdam, Netherlands : 1988)|March 6, 2012
T Schiffer, F Aurenhammer, M Demuth
Pageof 18